CD4 and neoplasm: Genetic alterations leading to loss of MHC Class I, MHC Class II, and CD58 contribute to the failure of CD 8+ T lymphocyte, CD4+ lymphocyte, and NK cell-mediated tumor cytotoxicity (52).